Techno Medical PCL (BKK:TM)

Techno Medical PCL Financials Overview

Financials in millions THB. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	717.45	706.09	725.72	697.01	645.04	675.45
Revenue Growth	0.12%	-2.71%	4.12%	8.06%	-4.50%	6.94%
Gross Profit Gross Profit Growth	260.87	251.22	231.33	231.51	230.71	257.13
Operating Income Operating Income Growth	47.69	45.73	3.87	6.88	18.56	55.12
Net Income Net Income Growth	28.85	27.51	-21.64	-4.49	12.99	30.5
Earnings Per Share EPS Growth	0.09	0.09	-0.07	-0.01	0.04	0.10
EPS Growth	-	-	-	-	-58.18%	-25.56%

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Sales of Disposable Equipment and Supplies Sales of Disposable Equipment and Supplies Growth	684.97	674.65	699.31	657.2	612.93	647.4
Sales of Medical Equipment and Instrument Sales of Medical Equipment and Instrument Growth	7.55	7.94	10.42	28.56	29.94	26.74
Services Relating To Nursing Care Services Relating To Nursing Care Growth	24.02	22.57	15.46	10.25	-	-
Unallocated Other Income Unallocated Other Income Growth	0.91	0.93	0.54	-	-	29.5
Total Total Growth	717.45	706.09	725.72	696.02	642.86	703.64

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	41.3	42.26	44.22	72.39	100.07	156.09
Total Debt Total Debt Growth	328.91	324.09	351.12	385.27	305.77	219.36
Net Cash (Debt) Net Cash Growth	-287.61	-281.82	-306.9	-312.88	-205.7	-63.27
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.93	-0.92	-1.00	-1.02	-0.65	-0.21

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	425.73	443.88	464.8	-17.82	15.53	42.81
Capital Expenditures CapEx Growth	-7.73	-5.65	-10.79	-54.15	-125.89	-91.45
Free Cash Flow Free Cash Flow Growth	418	438.24	454.01	-71.97	-110.37	-48.65
Free Cash Flow Growth	-28.69%	-3.48%	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	36.36%	35.58%	31.88%	33.21%	35.77%	38.07%
Operating Margin	6.65%	6.48%	0.53%	0.99%	2.88%	8.16%
Pretax Margin	5.05%	4.84%	-3.62%	-0.44%	2.63%	6.69%
Profit Margin	4.02%	3.90%	-2.98%	-0.64%	2.01%	4.52%
FCF Margin	58.26%	62.07%	62.56%	-10.32%	-17.11%	-7.20%

Dividends

Chart

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.033	0.050	0.085
Dividend Per Share Growth	-34.00%	-41.18%	-15.00%
Dividend Yield	1.68%	1.94%	2.53%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 11, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	9.62	11.31	-	-	63.55	36.15
Forward PE	-	15.41	15.41	15.41	15.41	15.41
P/FCF Ratio	0.66	0.71	0.67	-	-	-
PS Ratio	0.39	0.44	0.42	0.88	1.28	1.63

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error